Topics

IPO Update: 35 Biopharmas Provide -6.1% Average Return; New Offerings Feel Stock Market Impact

19:31 EDT 2 Oct 2019 | SCRIP

Only 16 drug developers that went public in the US during the first three quarters are trading in positive territory...

      

Related Stories

 

Original Article: IPO Update: 35 Biopharmas Provide -6.1% Average Return; New Offerings Feel Stock Market Impact

NEXT ARTICLE

More From BioPortfolio on "IPO Update: 35 Biopharmas Provide -6.1% Average Return; New Offerings Feel Stock Market Impact"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...